Elsevier is a world-leading provider of information solutions that enhance the performance of health profesionals, science and technology researchers, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey — and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries.
RELX Group is owned by two parent companies. Reed Elsevier PLC is the London Stock Exchange listed vehicle for holding shares in RELX Group. Reed Elsevier NV is the Amsterdam Stock Exchange listed vehicle for holding shares in RELX Group.
Lead the way in advancing science, technology and health.
Our customers are doing momentous things, and we are uniquely positioned to show our customers the ‘art of the possible’.
For more than 130 years we have shared their commitment to transforming and advancing science, health and technology. We understand the worlds in which clinicians, educators, and academic and corporate researchers work, the outcomes they want to achieve and the challenges they face in achieving them.
We have a responsibility to use that understanding to create highly effective solutions that enable our customers to leverage the vast potential of information to advance science, health and technology in ways that they could not do alone, and to anticipate the new ways customers will want to use information in the future. That is what we mean by ‘leading the way’.
Senior Management – Elsevier Health, South Asia